Industry: Pharmaceuticals, Biotechnology
Abraxis BioScience, Inc. is an integrated global biopharmaceutical company dedicated to meeting the needs of critically ill patients. The company develops, manufactures and markets one of the broadest portfolios of injectable products and leverages revolutionary technology such as its nab platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life-threatening diseases. The first FDA approved product to use this nab platform, ABRAXANE(R), was launched in 2005 for the treatment of metastatic breast cancer. Abraxis trades on the Nasdaq Global Market under the symbol ABBI. ( www.abraxisbio.com )
Abraxis BioScience , Inc.
1501 East Woodfield Road Suite 300 East
Schaumburg, Illinois 60173-5837
USA
Tel: (847) 969-2700
Fax: (800) 743-7082